Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine maintenance trial for prevention of mood episode recurrence in bipolar I disorder
2010-018671-20Phase 3Completed
- Sponsor
- Forest Research Institute
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Asenapine with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2012; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2010-018671-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018671-20.